Literature DB >> 27664260

Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

E C Smyth1, M Verheij2, W Allum3, D Cunningham4, A Cervantes5, D Arnold6.   

Abstract

Entities:  

Year:  2016        PMID： 27664260     DOI： 10.1093/annonc/mdw350

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  431 in total

Review 1.  Research progress on gut microbiota in patients with gastric cancer, esophageal cancer, and small intestine cancer.

Authors:  Changchang Chen; Linjie Chen; Lijun Lin; Dazhi Jin; Yaoqiang Du; Jianxin Lyu
Journal:  Appl Microbiol Biotechnol       Date:  2021-05-26       Impact factor: 4.813

2.  Prognostic and Predictive Value of Microsatellite Instability, Inflammatory Reaction and PD-L1 in Gastric Cancer Patients Treated with Either Adjuvant 5-FU/LV or Sequential FOLFIRI Followed by Cisplatin and Docetaxel: A Translational Analysis from the ITACA-S Trial.

Authors:  Maria Di Bartolomeo; Federica Morano; Alessandra Raimondi; Rosalba Miceli; Salvatore Corallo; Elena Tamborini; Federica Perrone; Maria Antista; Monica Niger; Alessandro Pellegrinelli; Giovanni Randon; Filippo Pagani; Antonia Martinetti; Giovanni Fucà; Filippo Pietrantonio
Journal:  Oncologist       Date:  2019-11-25

3.  Current management of liver metastases from gastric cancer: what is common practice? New challenge of EORTC and JCOG.

Authors:  Kozo Kataoka; Takahiro Kinoshita; Markus Moehler; Murielle Mauer; Kohei Shitara; Anna Dorothea Wagner; Stefanie Schrauwen; Takaki Yoshikawa; Franco Roviello; Masanori Tokunaga; Narikazu Boku; Michel Ducreux; Masanori Terashima; Florian Lordick
Journal:  Gastric Cancer       Date:  2017-02-01       Impact factor: 7.370

4.  Comparative effectiveness of adjuvant treatments for resected gastric cancer: a network meta-analysis.

Authors:  Zhaolun Cai; Yiqiong Yin; Yuan Yin; Chaoyong Shen; Jian Wang; Xiaonan Yin; Zhixin Chen; Ye Zhou; Bo Zhang
Journal:  Gastric Cancer       Date:  2018-05-04       Impact factor: 7.370

5.  Treatment Patterns Among Patients with Metastatic and/or Unresectable Gastric Cancer in Brazil.

Authors:  Fernando Meton de Alencar Camara Vieira; Ana Paula Ornellas de Souza Victorino; Daniel de Iracema Gomes Cubero; Carlos Augusto de Mendonça Beato; Eimy Minowa; Guilherme Silva Julian; Diego Novick
Journal:  J Gastrointest Cancer       Date:  2019-12

Review 6.  Clinical Impact of a Perioperative Exercise Program for Sarcopenia and Overweight/Obesity Gastric Cancer.

Authors:  Toru Aoyama; Masato Nakazono; Shinsuke Nagasawa; Kenki Segami
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

7.  Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial.

Authors:  Charles S Fuchs; Toshihiko Doi; Raymond W Jang; Kei Muro; Taroh Satoh; Manuela Machado; Weijing Sun; Shadia I Jalal; Manish A Shah; Jean-Phillipe Metges; Marcelo Garrido; Talia Golan; Mario Mandala; Zev A Wainberg; Daniel V Catenacci; Atsushi Ohtsu; Kohei Shitara; Ravit Geva; Jonathan Bleeker; Andrew H Ko; Geoffrey Ku; Philip Philip; Peter C Enzinger; Yung-Jue Bang; Diane Levitan; Jiangdian Wang; Minori Rosales; Rita P Dalal; Harry H Yoon
Journal:  JAMA Oncol       Date:  2018-05-10       Impact factor: 31.777

Review 8.  Challenges surrounding postoperative adjuvant chemotherapy for T2N0 gastric cancer.

Authors:  Ke-Kang Sun; Qing-Hua Wang; Yong-You Wu
Journal:  Oncol Lett       Date:  2020-08-19       Impact factor: 2.967

9.  Immunohistochemical classification of gastric cancer based on new molecular biomarkers: a potential predictor of survival.

Authors:  Cristina Díaz Del Arco; Lourdes Estrada Muñoz; Elena Molina Roldán; Mª Ángeles Cerón Nieto; Luis Ortega Medina; Soledad García Gómez de Las Heras; Mª Jesús Fernández Aceñero
Journal:  Virchows Arch       Date:  2018-08-23       Impact factor: 4.064

10.  Expression and clinical significance of miR-338 and miR-20a in serum of patients with gastric carcinoma.

Authors:  Min Li; Jueping Feng; Chang Gao; Wen Sun; Yilian Chen
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.